CATALOGO DEI PRODOTTI DELLA RICERCA

Zaza, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.860
EU - Europa 7.630
AS - Asia 5.189
SA - Sud America 786
Continente sconosciuto - Info sul continente non disponibili 458
AF - Africa 112
OC - Oceania 12
Totale 23.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.675
RU - Federazione Russa 2.814
SG - Singapore 2.000
CN - Cina 1.552
GB - Regno Unito 1.522
IT - Italia 932
BR - Brasile 602
SE - Svezia 556
FR - Francia 499
VN - Vietnam 472
HK - Hong Kong 403
DE - Germania 360
IE - Irlanda 352
FI - Finlandia 255
KR - Corea 175
IN - India 108
CA - Canada 94
BD - Bangladesh 86
UA - Ucraina 80
ID - Indonesia 73
AR - Argentina 72
TR - Turchia 45
AT - Austria 42
JP - Giappone 42
MX - Messico 42
PK - Pakistan 39
BE - Belgio 34
IQ - Iraq 34
ZA - Sudafrica 34
NL - Olanda 30
PL - Polonia 29
EC - Ecuador 27
CO - Colombia 26
ES - Italia 24
PH - Filippine 21
VE - Venezuela 18
MA - Marocco 14
NG - Nigeria 14
RO - Romania 14
MY - Malesia 13
UZ - Uzbekistan 13
CL - Cile 12
SA - Arabia Saudita 12
AU - Australia 11
CZ - Repubblica Ceca 11
IL - Israele 11
PY - Paraguay 11
CH - Svizzera 10
GR - Grecia 10
AZ - Azerbaigian 9
JO - Giordania 9
DZ - Algeria 8
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DK - Danimarca 7
KE - Kenya 7
KZ - Kazakistan 7
NI - Nicaragua 7
PE - Perù 7
PS - Palestinian Territory 7
EG - Egitto 6
GE - Georgia 6
HN - Honduras 6
LB - Libano 6
LT - Lituania 6
NP - Nepal 6
BO - Bolivia 5
EU - Europa 5
LV - Lettonia 5
RS - Serbia 5
TN - Tunisia 5
XK - ???statistics.table.value.countryCode.XK??? 5
DO - Repubblica Dominicana 4
HR - Croazia 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
OM - Oman 4
SV - El Salvador 4
TG - Togo 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
CI - Costa d'Avorio 3
ET - Etiopia 3
KG - Kirghizistan 3
NO - Norvegia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BJ - Benin 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
GT - Guatemala 2
GY - Guiana 2
LK - Sri Lanka 2
ME - Montenegro 2
MK - Macedonia 2
Totale 22.561
Salva come PNG Salva come JPEG
Città #
Ashburn 1.407
Southend 1.312
Singapore 1.036
Moscow 943
San Jose 890
Chandler 877
Dallas 531
Jacksonville 466
Hong Kong 397
Council Bluffs 363
Dublin 341
Verona 298
Beijing 266
Woodbridge 262
Ann Arbor 235
The Dalles 225
New York 198
Wilmington 156
Los Angeles 152
Lawrence 150
Princeton 150
Ho Chi Minh City 120
Houston 108
Jinan 102
Santa Clara 97
Buffalo 86
Columbus 81
Redmond 80
Shenyang 80
Hanoi 75
Nanjing 72
Sindelfingen 66
Tianjin 63
Redondo Beach 61
São Paulo 61
Hebei 59
Munich 58
Dong Ket 57
Helsinki 55
Rome 48
Seattle 47
Chicago 46
Orem 46
Milan 45
Tokyo 41
Changsha 40
Jakarta 37
Taizhou 37
Montreal 36
Ningbo 35
Redwood City 35
Boardman 34
Brussels 33
Turku 33
Phoenix 32
Zhengzhou 32
Haikou 30
Lancaster 29
Brooklyn 28
San Francisco 28
Atlanta 27
Jiaxing 27
Guangzhou 26
Kent 26
Nanchang 26
Vienna 26
Hangzhou 24
Nuremberg 24
Toronto 24
Rio de Janeiro 23
Seoul 22
Johannesburg 21
Taiyuan 21
Chennai 20
Denver 20
Frankfurt am Main 20
Warsaw 19
Bologna 18
Amsterdam 17
London 17
Mianwali 17
Norwalk 17
Shanghai 17
Washington 17
Baghdad 15
Da Nang 15
Lanzhou 15
Brasília 14
Hyderabad 14
Porto Alegre 14
Bari 13
Boston 13
Quito 13
Stockholm 13
Abuja 12
Ankara 12
Barnet 12
Biên Hòa 12
Bogotá 12
Falkenstein 12
Totale 13.535
Salva come PNG Salva come JPEG
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 503
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 305
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 270
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 263
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 255
Identificazione del primo biomarcatore diagnostico urinario per il rene a spugna midollare (MSK): risultato di uno studio di proteomica mediante spettrometria di massa 227
Terapia della glomerulonefrite membrano proliferativa. 217
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 215
Liver Metastases From Renal Oncocytoma With Vascular Extension 214
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 211
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 207
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 205
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 201
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 200
mTOR inhibitors and renal allograft: Yin and Yang. 196
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 195
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 195
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 194
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 193
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 193
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 193
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 190
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 190
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 189
Caratterizzazione del profilo trascrittomico nei linfomonociti periferici di trapiantati renali con rigetto cronico anticorpo-mediato (RCAM) 187
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 187
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 186
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 186
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 186
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 184
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 184
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 180
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 180
Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy 179
Donor-transmitted cancer in kidney transplant recipients: a systematic review 178
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis 178
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 177
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 176
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 176
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 175
Assessment of physical performance and body composition in male renal transplant patients 175
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 175
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 174
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 173
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 172
Sulodexide and glycosaminoglycans in the progression of renal disease. 170
How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network 170
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 168
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 168
Directional dominance on stature and cognition in diverse human populations. 168
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 168
Dialysis-related systemic microinflammation is associated with specific genomic patterns 167
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 165
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 165
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 164
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 163
Post-renal transplant pregnancy: a project to plan carefully 162
mTOR Inhibition Role in Cellular Mechanisms 161
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 161
Mitochondria: a new therapeutic target in chronic kidney disease. 160
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 159
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 158
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 158
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 157
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 157
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 156
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 156
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 155
Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients 155
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 152
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 152
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 151
Impact of 3 Major Maintenance Immunosuppressive Protocols on Long-term Clinical Outcomes: Result of a Large Multicenter Italian Cohort Study Including 5635 Renal Transplant Recipients. 151
Aberrantly Methylated DNA Regions Lead to Low Activation of CD4+ T Cells in IgA Nephropathy. 150
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 150
Late recovery of renal function in a patient with acute on chronic renal failure treated with peritoneal dialysis. 149
Alla ricerca di biomarker predittivi della ritardata ripresa funzionale del rene trapiantato: un utilizzo innovativo della genomica funzionale in trapiantologia. 148
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis 148
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 147
Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis 147
The UK10K project identifies rare variants in health and disease. 145
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 145
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 144
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy. 144
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 143
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review. 143
INCIDENCE OF PRIMARY GLOMERULONEPHRITIS IN A LARGE NORTH-EASTERN ITALIAN AREA: A 13-YEAR RENAL BIOPSY STUDY 142
Heparanase: another renal player controlled by vitamin d. 142
Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. 142
Analysis of urinary exosomes applications for rare kidney disorders. 142
Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment 141
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 139
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 138
Copy Number Variant Analysis and Genome-wide Association Study Identify Loci with Large Effect for Vesicoureteral Reflux 138
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. 134
Predictive model for delayed graft function based on easily available pre-renal transplant variables 133
Compiti e funzioni dei Centri Interregionali Trapianto 133
Risk of Hospitalization and Death From COVID-19 Infection in Patients With Chronic Plaque Psoriasis Receiving a Biologic Treatment and Renal Transplant Recipients in Maintenance Immunosuppressive Treatment 133
The nephrologist of tomorrow: towards a kidney-omic future. 133
HFR aequilibrium can be an answer to malnutrition and hypotension in dialisys: case report 132
Totale 17.511
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.902
article - articoli 75.728
book - libri 0
conference - conferenze 4.566
curatela - curatele 0
other - altro 625
patent - brevetti 0
selected - selezionate 0
volume - volumi 983
Totale 163.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022778 0 0 0 194 29 32 35 77 45 26 91 249
2022/20232.536 174 342 230 450 200 564 31 142 275 12 87 29
2023/20241.431 60 100 101 118 145 188 33 366 6 69 189 56
2024/20253.090 166 225 122 558 158 96 131 172 465 181 274 542
2025/20269.081 653 450 546 1.444 2.237 674 810 501 654 570 152 390
2026/20271.033 111 227 319 376 0 0 0 0 0 0 0 0
Totale 23.047